1 / 9

CASE 1

CASE 1 . 68 yo man HIV+…1988 HepBsAg (+) HepBeAg (+) No baseline HBV DNA/Liver Biopsy Secondary workup for liver disease negative. CASE 1 . 3TC-based HIV therapy from 1997-2001 CD4 630/37% HIV Viral load <50. CASE 1 .

razi
Download Presentation

CASE 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CASE 1 • 68 yo man • HIV+…1988 • HepBsAg(+) HepBeAg (+) • No baseline HBV DNA/Liver Biopsy • Secondary workup for liver disease negative

  2. CASE 1 • 3TC-based HIV therapy from 1997-2001 • CD4 630/37% • HIV Viral load <50

  3. CASE 1 • Tenofovir added to HIV medications (including 3TC) in response to elevated HBV DNA on 3TC monotherapy…no biopsy or assessment of fibrosis done but no obvious cirrhosis/portal hypertension

  4. CASE 1 Fenofibrate/Ramipril/Tenofovireod therapy

  5. CASE 1 • Dec 2010 – Apr 2011 • Fenofibrate/Ramipril/Tenofovireod discontinued in 1/11 WHAT IS GOING ON? WOULD WOULD YOU DO?

  6. CASE 1 • Renal biopsy performed due to blood in urine, increased proteinuria and increasing creatinine • Interstitial fibrosis/tubular atrophy • 2/9 glomerulisclerosed • Mild arterial sclerosis • No active disease Probably an ischemic insult

  7. CASE 1 May 2011– Nov 2011 No Tenofovir/Ramipril/Fenofibrate

  8. CASE 1 • HepBeAg (+), 3TC based HIV therapy • U/S –fatty liver

  9. CASE 1 • Fibrotest 0.74 → F3 scarring • Fibroscan in agreement HOW WOULD YOU MANAGE HIS HEPATITIS B?

More Related